Status:

COMPLETED

Pinnacle Metal-on-Metal 522 Post-Market Surveillance Study

Lead Sponsor:

DePuy Orthopaedics

Conditions:

Pinnacle Metal-on-Metal

Revised Pinnacle Metal-on-Metal

Eligibility:

All Genders

Brief Summary

The purpose of this clinical study is to evaluate blood metal ion levels as a function of time of implantation for the Pinnacle Acetabular MoM system.

Eligibility Criteria

Inclusion

  • Able to (or capable of) provide written, voluntary consent to participate in the clinical investigation
  • Is willing and able to return for all protocol defined clinic visits
  • Subject has a combination of the following implants in the study hip (unless in pre-op cohort):
  • Pinnacle acetabular shell with or without Gription TM porous coating
  • M-specification cobalt-chrome femoral head or aSphere M-specification cobalt-chrome femoral head
  • Ultamet metal insert
  • One of the following stems
  • i. S-ROM ii. Corail iii. Tri-Lock iv. AML v. Summit vi. Prodigy vii. C-Stem
  • Subject has high quality films available for review that were taken within 12 months of the primary surgery of the following views:
  • Standing AP-Pelvis
  • Standing AP-Proximal Femur (if this view is not available but the AP-Pelvis shows the entire implant and greater trochanter, that is also acceptable)
  • Lauenstein Lateral Proximal Femur (Lateral-Femur)

Exclusion

  • The subject refuses to allow their medical records to be inspected by the Sponsor, representatives of the Sponsor, the medical office staff and/or representatives from FDA
  • The implanted hip components in the study hip (exclusive of cement), are not all DePuy components (unless in pre-op cohort)
  • The primary procedure occurred greater than 8 (eight) years ago (unless in pre-op cohort)
  • FOR PRE-OPERATIVE COHORT ONLY: the subject has a MoM contralateral hip
  • FOR PRE-OPERATIVE COHORT ONLY: the subject is undergoing a revision of the Ipsilateral hip

Key Trial Info

Start Date :

March 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2016

Estimated Enrollment :

276 Patients enrolled

Trial Details

Trial ID

NCT01828801

Start Date

March 1 2013

End Date

August 1 2016

Last Update

September 26 2016

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Orange, California, United States

2

Fort Collins, Colorado, United States

3

Lone Tree, Colorado, United States

4

Syracuse, New York, United States